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Introduction
Interstitial	lung	disease	(ILD)	is	a	diverse	group	of	lung	diseases	that	can	be	associated	with	
various	connective	tissue	diseases	including	polymyositis	and	dermatomyositis	(PM-DM).	
The	occurrence	of	ILD	in	patients	with	PM-DM	varies	widely	among	case	studies,	ranging	
from	20-80%.1		It	has	been	previously	reported	that	interstitial	lung	disease	(ILD)	may	be	a	
presenting	feature	of	polymyositis	(PM),2-3	however	the	diagnosis	of	PM	may	be	missed	if	
patients	do	not	present	with	other	symptoms	typically	associated	with	PM.
Case Report
A	53	year	old	hispanic	female	presented	to	the	hospital	with	a	two	week	history	of	dry	
cough	and	dyspnea	on	exertion.	A	CT	scan	of	the	chest	excluded	pulmonary	emboli	but	
showed	bilateral	lower	lobe	consolidations	and	she	was	started	
on	treatment	for	community	acquired	pneumonia.	She	did	
not	clinically	improve	with	antibiotics	and	deteriorated	to	the	
point	of	developing	ventilator-dependent	respiratory	failure.	
Microbial	workup	for	both	fungus	and	bacteria,	including	
bronchial	washings	obtained	via	bronchoscopy	were	negative.	
Hepatitis,	HIV,	comprehensive	ANA	panel	(ANA,	SS-A,	SS-B,	
SCL-70,	dS-DNA,	SM/RNP,	RF,	CCP),	c-ANCA	and	p-ANCA	were	
also	negative.	A	lung	biopsy	was	performed	which	revealed	
findings	consistent	with	cryptogenic	organizing	pneumonia	
(COP).	She	was	empirically	started	on	prednisone	with	gradual	
clinical	improvement	and	was	eventually	discharged	home	with	
a	prolonged	prednisone	taper	and	on	two	liters	of	oxygen	via	
nasal	cannula.	Four	months	after	her	initial	presentation,	she	
presented	with	new	symptoms	of	arthralgias,	lower	extremity	
weakness,	and	joint	swelling	of	bilateral	wrists,	hands	and	
knees.	Increased	CPK,	aldolase,	and	positive	anti-Jo-1	antibodies	
were	identified.	A	muscle	biopsy	showed	findings	consistent	with	
polymyositis.	She	was	diagnosed	with	PM	and	started	on	high	
dose	corticosteroids.	Her	symptoms	of	lower	extremity	weakness	
significantly	improved,	however	she	still	remained	oxygen	
dependent	on	two	liters	nasal	cannula	secondary	to	unresolved	
ILD.	She	was	discharged	home	on	high	dose	prednisone	with	
close	out-patient	follow	up	with	rheumatology.	
Discussion
Although	proximal	muscle	weakness	is	the	most	frequent	clinical	manifestation	and	the	
presenting	symptom	in	80%	of	patients	with	PM,	ILD	maybe	an	early	manifestation	in	patients	
with	anti-Jo-1-positive	PM-DM	and	may	precede	the	onset	of	myositis.2-4	
The	presence	of	antisynthetase	antibodies	in	PM-DM	appears	to	be	associated	with	a	greater	
probability	of	developing	ILD;	one	retrospective	case	series	of	anti-Jo-1	antibody-positive	
individuals	reported	the	incidence	of	ILD	as	high	as	86%.5	
ILD	has	been	reported	to	precede	the	onset	of	muscle	involvement	by	months	or	even	years,	
appear	at	the	same	time	as	symptoms	of	myositis,	or	months	after	the	development	of	muscle	
involvement.1,	4	
The	patterns	of	lung	pathology	that	have	been	found	to	be	associated	with	DM	and	PM	
include:	idiopathic	interstitial	pneumonias,	including	nonspecific	interstitial	pneumonia,	usual	
interstitial	pneumonia,	organizing	pneumonia,	and	acute	interstitial	pneumonitis.4	
The	initial	treatment	for	ILD	in	patients	with	PM-DM	include	systemic	glucocorticoids	at	a	
dose	of	1mg/kg	per	day.	ILD	in	PM	is	associated	with	a	high	rate	of	morbidity	and	mortality6	
and	often	require	a	second	immunosuppressive	agent	to	slow	the	progression	of	ILD	and	to	
enable	tapering	of	glucocorticoids.	
Conclusion
This	case	demonstrates	that	ILD	maybe	the	initial	presentation	of	PM-DM,	thereby	preceding	
the	symptoms	of	myositis.	Therefore,	PM-DM	must	remain	within	the	differential	of	ILD	in	
order	to	prevent	a	delayed	diagnosis	which	can	be	associated	with	significantly	increased	
morbidity	and	mortality	secondary	to	progression	of	the	disease.	This	case	also	highlights	the	
utility	of	anti-Jo-1	as	both	a	marker	for	polymyositis	and	its	use	in	the	evaluation	of	patients	
with	ILD	of	unclear	etiology.	
Figure 1: Patient’s	CT	Scan	showing	
bilateral	lower	lobe	consolidation	and	diffuse	
groundglass	opacities.
Figure 2: Example	of	polymyositis	muscle	
biopsy.	Cellular	infiltrate	is	predominantly	
within	the	fascicle,	with	inflammatory	cells	
invading	individual	muscle	fibers.1
